Skip to main content

Onfi FDA Approval History

FDA Approved: Yes (First approved October 21, 2011)
Brand name: Onfi
Generic name: clobazam
Dosage form: Tablets
Company: Lundbeck Inc.
Treatment for: Lennox-Gastaut Syndrome

Onfi (clobazam) is a benzodiazepine antiepileptic drug for the treatment of patients with Lennox-Gastaut syndrome (LGS).

Development timeline for Onfi

DateArticle
Oct 24, 2011Approval FDA Approves Onfi for Seizures Associated with Lennox-Gastaut Syndrome
Mar  4, 2011FDA Accepts Lundbeck Inc. Submission of New Drug Application for Clobazam
Jun 11, 2010H. Lundbeck A/S (DK) - Lundbeck will submit an NDA for clobazam for patients with Lennox-Gastaut syndrome with the FDA before year end 2010

See also

Onfi (clobazam) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer